| Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue S Kern, H Eichler, J Stoeve, H Klüter, K Bieback Stem cells 24 (5), 1294-1301, 2006 | 4375 | 2006 |
| Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood K Bieback, S Kern, H Klüter, H Eichler Stem cells 22 (4), 625-634, 2004 | 1368 | 2004 |
| Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling K Bieback, E Lien, IM Klagge, E Avota, J Schneider-Schaulies, ... Journal of virology 76 (17), 8729-8736, 2002 | 694 | 2002 |
| Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow K Bieback, A Hecker, A Kocaömer, H Lannert, K Schallmoser, D Strunk, ... Stem cells 27 (9), 2331-2341, 2009 | 624 | 2009 |
| Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue A Kocaoemer, S Kern, H Klüter, K Bieback Stem cells 25 (5), 1270-1278, 2007 | 552 | 2007 |
| Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells G Siegel, T Kluba, U Hermanutz-Klein, K Bieback, H Northoff, R Schäfer BMC medicine 11, 1-20, 2013 | 523 | 2013 |
| Stem cell migration and mechanotransduction on linear stiffness gradient hydrogels WJ Hadden, JL Young, AW Holle, ML McFetridge, DY Kim, P Wijesinghe, ... Proceedings of the National Academy of Sciences 114 (22), 5647-5652, 2017 | 489 | 2017 |
| Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate L Bunse, S Pusch, T Bunse, F Sahm, K Sanghvi, M Friedrich, D Alansary, ... Nature medicine 24 (8), 1192-1203, 2018 | 438 | 2018 |
| Fetal bovine serum (FBS): past–present–future J Van der Valk, K Bieback, C Buta, B Cochrane, WG Dirks, J Fu, ... ALTEX-Alternatives to animal experimentation 35 (1), 99-118, 2018 | 415 | 2018 |
| Is the intravascular administration of mesenchymal stem cells safe?: Mesenchymal stem cells and intravital microscopy D Furlani, M Ugurlucan, LL Ong, K Bieback, E Pittermann, I Westien, ... Microvascular research 77 (3), 370-376, 2009 | 396 | 2009 |
| Intravascular mesenchymal stromal/stem cell therapy product diversification: time for new clinical guidelines G Moll, JA Ankrum, J Kamhieh-Milz, K Bieback, O Ringdén, HD Volk, ... Trends in molecular medicine 25 (2), 149-163, 2019 | 339 | 2019 |
| Comparing the immunomodulatory properties of bone marrow, adipose tissue, and birth-associated tissue mesenchymal stromal cells P Mattar, K Bieback Frontiers in immunology 6, 560, 2015 | 317 | 2015 |
| Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures K Bieback Transfusion Medicine and Hemotherapy 40 (5), 326-335, 2013 | 253 | 2013 |
| Mesenchymal stromal cells from umbilical cord blood K Bieback, H Kluter Current stem cell research & therapy 2 (4), 310-323, 2007 | 234 | 2007 |
| Comparing mesenchymal stromal cells from different human tissues: bone marrow, adipose tissue and umbilical cord blood K Bieback, S Kern, A Kocaömer, K Ferlik, P Bugert Bio-medical materials and engineering 18 (s1), 71-76, 2008 | 228 | 2008 |
| Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy K Bieback, I Brinkmann World journal of stem cells 2 (4), 81, 2010 | 189 | 2010 |
| Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration R Gaebel, D Furlani, H Sorg, B Polchow, J Frank, K Bieback, W Wang, ... Plos one 6 (2), e15652, 2011 | 179 | 2011 |
| Standardization of Good Manufacturing Practice–compliant production of bone marrow–derived human mesenchymal stromal cells for immunotherapeutic applications P Wuchter, K Bieback, H Schrezenmeier, M Bornhaeuser, LP Mueller, ... Cytotherapy 17 (2), 128-139, 2015 | 165 | 2015 |
| Cryopreserved or fresh mesenchymal stromal cells: only a matter of taste or key to unleash the full clinical potential of MSC therapy? G Moll, S Geißler, R Catar, L Ignatowicz, MJ Hoogduijn, D Strunk, ... Biobanking and cryopreservation of stem cells, 77-98, 2016 | 160 | 2016 |
| Hypoxic preconditioning increases survival and pro-angiogenic capacity of human cord blood mesenchymal stromal cells in vitro AM Bader, K Klose, K Bieback, D Korinth, M Schneider, M Seifert, ... PLoS One 10 (9), e0138477, 2015 | 139 | 2015 |
Dirk StrunkProfessor of Cell Therapy, Paracelsus Medical University在 pmu.ac.at 的电子邮件经过验证
Dirk StrunkProfessor of Cell Therapy, Paracelsus Medical University在 pmu.ac.at 的电子邮件经过验证
W Paul DuprexUniversity of Pittsburgh在 pitt.edu 的电子邮件经过验证